Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: ArthroCare/Boston Scientific

This article was originally published in The Gray Sheet

Executive Summary

Enter agreement under which Boston Scientific acquires exclusive licensing rights to develop and market ArthroCare's Coblation technology for use in myocardial revascularization. Boston Scientific will pay licensing fees to Sunnyvale, California-based ArthroCare upon achievement of designated clinical and regulatory milestones, and royalties on sales of resulting products. Specific terms of the agreement were not disclosed. ArthroCare began marketing the technology in December 1995 for use in arthroscopic surgery following FDA clearance ("The Gray Sheet" Jan. 26, 1996, p. 22)...
Advertisement

Related Content

Stryker Licenses ArthroCare Coblation Technology Following Serfas Launch
Stryker Licenses ArthroCare Coblation Technology Following Serfas Launch
Advertisement
UsernamePublicRestriction

Register

MT009618

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel